Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Kineret to treat deficiency of IL-1 receptor antagonist

Dec. 23, 2020

FDA approves Ebanga for the treatment of Zaire ebolavirus

Dec. 23, 2020

EC grants approval for Libmeldy gene therapy as treatment of early-onset MLD

Dec. 22, 2020

FDA issues EUA for Moderna's mRNA-1273 for COVID-19

Dec. 21, 2020

FDA approves Orgovyx for advanced prostate cancer

Dec. 21, 2020

Benlysta approved as the first therapy for adult patients with active lupus nephritis in the U.S.

Dec. 18, 2020

FDA approves Margenza for pretreated metastatic HER2-positive breast cancer

Dec. 17, 2020

FDA approves Klisyri for actinic keratosis on the face or scalp

Dec. 15, 2020

Leqvio approved in Europe for the treatment of hypercholesterolemia or mixed dyslipidemia

Dec. 14, 2020

FDA approves oral once-daily Orladeyo to prevent HAE attacks

Dec. 4, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...